D36HIV funding and access to treatment in sub-Saharan AfricaE-posterImpact of donor agencies’ policies and international financing initiatives
D36FY19-20 local vs. international PEPFAR prime partner performanceE-posterImpact of donor agencies’ policies and international financing initiatives
D41Estimated cost-based generic prices for key ARVs and effect of COVID-19 on manufacturing costsE-posterImpact of COVID-19 on HIV funding
D2Improving health equity and ending the HIV epidemic in the United States: a distributional cost-effectiveness analysis in six citiesOn-demand oral abstract sessionImpact evaluation of differentiated service delivery
D2Factors associated with 12-month retention after referral to a differentiated service delivery for HIV treatment model in ZambiaOral abstract session with live Q&AImpact evaluation of differentiated service delivery
D2VIBRA trial ' Village-based refill of ART following home-based same-day ART initiation: a cluster-randomized clinical trialOral abstract session with live Q&AImpact evaluation of differentiated service delivery
D2The Community HIV Epidemic Control Model: a community-based intervention to achieve 90-90-90 via comprehensive HIV differentiated service delivery in rural communities in ZambiaOral abstract session with live Q&AImpact evaluation of differentiated service delivery
D2Community-based prevention of mother-to-child HIV transmission increases engagement in antenatal care for women and infants in Zambia: results from the SMACHT projectE-posterImpact evaluation of differentiated service delivery
D2'Stable patients' need health services too: HIV-related symptoms are common amongst people eligible for less-intensive differentiated service delivery treatment models in Harare, ZimbabweE-posterImpact evaluation of differentiated service delivery
D2Scaling up the community eMTCT delivery system during COVID-19 pandemic lock down in Uganda - a case of TASO Gulu, Northern UgandaE-posterImpact evaluation of differentiated service delivery
481 - 490 of 870 items